OncoBreak: Amazon Drug Biz; Second Opinions; Sex During Chemo

— News, features, and commentary about cancer-related issues

MedpageToday

More perspectives and speculation about Amazon's plan to enter the retail pharmacy business. (MedCity News)

Sex during chemotherapy: What's safe, what's not? (ASCO Connection)

It's your right as a patient to seek a second opinion, and the American Cancer Society offers tips on how to go about it.

Another innovative strategy to improve historically poor outcomes in pancreatic cancer: Manipulation of exosomes. (MD Anderson Cancer Center)

Cancer patients allege an ingredient in a widely used weed killer caused their disease. (CNN)

The Senate passed legislation to reduce the burden of proof required to fire VA Health System employees. (Houston Chronicle)

New concern about health risks related to the nation's largest nuclear waste storage facility. (ABC News)

Pharma industry perspective on the recently concluded American Society of Clinical Oncology meeting. (Fierece Pharma)

CancerLinQ, a big-data initiative of the American Society of Clinical Oncology, will partner with the FDA and the National Cancer Institute to investigate how to make the best use of emerging data on different types of cancer and new cancer therapies.

The American Association for Cancer Research published screening recommendations for children with cancer predisposition syndromes.

The FDA granted breakthrough therapy designation for burtomab for treatment of children with relapsed or refractory neuroblastoma or leptomeningeal metastasis. (Business Wire)

A new educational initiative will seek to inform community oncologists more quickly about developments in the emerging field of immuno-oncology. (Association of Community Cancer Centers)

  • author['full_name']

    Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. He joined MedPage Today in 2007. Follow